AirSculpt Technologies, Inc. (AIRS) vs NervGen Pharma Corp. Common stock (NGEN)

A side-by-side comparison of AirSculpt Technologies, Inc. and NervGen Pharma Corp. Common stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
AirSculpt Technologies, Inc. logo
AIRS
AirSculpt Technologies, Inc.
$140M
$1.99HealthcareDelayed quote: Oct 6, 2026, 11:40 AM EDT
NervGen Pharma Corp. Common stock logo
NGEN
NervGen Pharma Corp. Common stock
$148M
$1.81HealthcareDelayed quote: Oct 6, 2026, 11:40 AM EDT

Total return — AIRS vs NGEN

growth of $100 · dividends reinvested · last 1y
AIRS -36.8% (-36.8%/yr)NGEN -57.6% (-57.6%/yr)AIRS compounded faster over this window
50100150200Start $1002026$63$42
AIRS NGEN

AIRS vs NGEN: by the numbers

  • •NGEN is the larger company ($148M vs $140M market cap).
  • •Both run net losses; NGEN's is the smaller (0.00% vs -7.79% net margin).

Metrics side by side

Valuation

MetricAIRSNGEN
P/S ratio0.93N/A
P/B ratio1.3412.18
EV / EBITDA451.01N/A
FCF yield0.54%N/A

Profitability

MetricAIRSNGEN
Gross margin57.63%0.00%
Operating margin-7.85%0.00%
Net margin-7.79%0.00%
ROE-11.20%-397.38%
ROIC-7.01%-223.90%

Growth (annualized)

MetricAIRSNGEN
Revenue CAGR (5Y)8.17%N/A
FCF CAGR (5Y)-52.36%N/A

Go deeper

Full AIRS analysisFull NGEN analysisInteractive comparison tool

Dig into the metrics

AirSculpt Technologies ROENervGen Pharma Corp. Common stock ROEAirSculpt Technologies operating marginNervGen Pharma Corp. Common stock operating marginAirSculpt Technologies revenue growthNervGen Pharma Corp. Common stock revenue growthAirSculpt Technologies free cash flowNervGen Pharma Corp. Common stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.